ZFP64 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-78187
Key Product Details
Validated by
Independent Antibodies, Biological Validation
Species Reactivity
Human, Mouse
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.2 mg/ml
Product Specifications
Immunogen
The immunogen for this product maps to a region between residue 400 and 450 of human Zinc finger protein 64 using the numbering given in entry NP_060667.2 (GeneID 55734).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ZFP64 Antibody
Western Blot: ZFP64 Antibody [NBP1-78187]
Western Blot: ZFP64 Antibody [NBP1-78187] - Whole cell lysate from 293T (15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), Jurkat (J; 50 mcg), HeLa (H; 50 mcg) and mouse NIH3T3 (M; 50 mcg) cells. Antibodies: Affinity purified rabbit anti-ZFP64 antibody used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. ZFP64 was also immunoprecipitated by another rabbit anti-ZFP64 antibody which recognizes a downstream epitope.Applications for ZFP64 Antibody
Application
Recommended Usage
Immunoprecipitation
2-10 ug/mg lysate
Western Blot
1:2000-1:10000
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
TBS and 0.1% BSA
Preservative
0.09% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: ZFP64
Alternate Names
dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, Zfp-64, Zinc finger protein 338MGC940, zinc finger protein 64, zinc finger protein 64 homolog (mouse), ZNF338
Gene Symbol
ZFP64
UniProt
Additional ZFP64 Products
Product Documents for ZFP64 Antibody
Product Specific Notices for ZFP64 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...